trending Market Intelligence /marketintelligence/en/news-insights/trending/i1uol4vl3utrhobif0c36q2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Zynex to buy back $2M of common stock

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Zynex to buy back $2M of common stock

Zynex, Inc. said its board approved a stock back program for an additional $2 million of the company's common stock.

The Englewood, Colo.-based developer of electrotherapy medical devices said the program will begin May 14 and terminate May 13, 2019, or when the $2 million buyback limit is reached.

Zynex expects to finance the share buyback with existing cash balances.

The company had undertaken a buyback program from Dec. 6, 2017, through March 6. It repurchased 495,091 common shares.